ORVILLE JACOB A 4

What Happened
Orville Jacob A, Senior Vice President of Abbott Laboratories (ABT), was granted 13,255 restricted shares on 2026-03-23. The Form 4 records the acquisition as an award (code A) at $0.00 per share (acquired value $0). This is a grant of restricted stock, not an open-market purchase or sale, and therefore does not by itself signal a buy or sell preference.

Key Details

• Transaction date: 2026-03-23; Form 4 filed: 2026-03-25 (timely filing).
• Security: 13,255 restricted common shares; reported acquisition price: $0.00.
• Vesting: 2-year term; one-half of the award vests in any one year, beginning March 23, 2027 (per footnote).
• Tax handling: Award includes the right to have shares withheld for tax purposes.
• Shares owned after the transaction: Not specified in the provided filing excerpt.
• Transaction code: A = Award/Grant.

Context
Restricted stock awards are compensation and typically vest over time; they differ from purchases or sales and do not necessarily reflect immediate trading intent. The filing appears timely (reported two days after the grant), and the award’s withholding feature means Abbott may hold back shares later to cover taxes when vesting occurs.